Back to search

Determination of Ribavirin in Serum Using Highly Selective Solid-Phase Extraction and High-Performance Liquid Chromatography

Data up to Jan 2025

Published2000
Citations56
References11

Total Citations Per Year

Abstract

References (11)

Interferon Alfa-2b Alone or in Combination with Ribavirin as Initial Treatment for Chronic Hepatitis C

1998 • 3,550 citations

Interferon Alfa-2b Alone or in Combination with Ribavirin for the Treatment of Relapse of Chronic Hepatitis C

1998 • 1,318 citations

Ribavirin and interferon alfa‐2b in chronic hepatitis C: assessment of possible pharmacokinetic and pharmacodynamic interactions

1998 • 146 citations

Ribavirin disposition in high-risk patients for acquired immunodeficiency syndrome

1987 • 109 citations

Pharmacokinetics and long-term tolerance to ribavirin in asymptomatic patients infected with human immunodeficiency virus

1991 • 81 citations

High-performance liquid chromatography (HPLC) assay for ribavirin and comparison of the HPLC assay with radioimmunoassay

1989 • 32 citations

Selective purification of reduced oligosaccharides using a phenylboronic acid bond elut column: Potential application in HPLC, mass spectrometry, reductive amination procedures and antigenic/serum analysis

1987 • 24 citations

Quantification of ribavirin in biological fluids and tissues by high-performance liquid chromatography

1987 • 24 citations

High-performance liquid chromatographic determination of ribavirin in serum and urine and of its urinary metabolite 1,2,4-triazole-3-carboxamide

1987 • 21 citations

Comparison of ribavirin and placebo in CDC group III human immunodeficiency virus infection

1991 • 12 citations

Treatment of chronic hepatitis C: another therapeutic option

1996 • 5 citations

Cited By (0)

No citing papers found in database

Determination of Ribavirin in Serum Using Highly Selective Solid-Phase Extraction and… (2000) – Therapeutic Drug Monitoring | Metascience Observatory Explorer